Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3–14 years from the provider and societal perspectives
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3–14 years: A prospective cohort studyVaccine, 2006
- The Underrecognized Burden of Influenza in Young ChildrenNew England Journal of Medicine, 2006
- Cost-effectiveness of influenza vaccination of healthy childrenVaccine, 2006
- Influenza-Associated Deaths among Children in the United States, 2003–2004New England Journal of Medicine, 2005
- An economic analysis of annual influenza vaccination of childrenVaccine, 2005
- Socioeconomic impact of influenza on healthy children and their familiesThe Pediatric Infectious Disease Journal, 2003
- Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the householdsVaccine, 2003
- Economic Impact of Influenza Vaccination in Preschool ChildrenPediatrics, 2000
- Effectiveness of Influenza Vaccination of Day Care Children in Reducing Influenza-Related Morbidity Among Household ContactsJAMA, 2000
- Potential Cost Savings Attributable to Influenza Vaccination of School-aged ChildrenPediatrics, 1999